Distinct roles of the Src family kinases, SRC-1 and KIN-22, that are negatively regulated by CSK-1 in C. elegans  by Hirose, Takashi et al.
Distinct roles of the Src family kinases, SRC-1 and KIN-22, that are
negatively regulated by CSK-1 in C. elegans
Takashi Hirosea;, Makoto Kogab, Yasumi Ohshimab, Masato Okadaa
aDepartment of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan
bDepartment of Biology, Faculty of Sciences, Kyushu University Graduate School, Fukuoka 812-8581, Japan
Received 10 October 2002; revised 5 December 2002; accepted 5 December 2002
First published online 17 December 2002
Edited by Giulio Superti-Furga
Abstract To elucidate the primitive roles of the Src family
kinases (SFKs), here we characterized Caenorhabditis elegans
orthologues of SFKs (src-1 and kin-22) and their regulator ki-
nase Csk (csk-1). SRC-1 and KIN-22 possess the C-terminal
regulatory tyrosines characteristic of SFKs, and their activities
are negatively regulated by CSK-1 in a yeast expression system.
The src-1 and csk-1 genes are co-expressed in some head neu-
rons, the anchor cell and the tail region, while kin-22 and csk-1
genes are co-expressed in pharyngeal muscles and tail region.
Expression of KIN-22 induced morphological defects in the
pharynx, whereas expression of SRC-1 did not show any overt
phenotype in adult. RNA interference of src-1, but not that of
kin-22, caused a developmental arrest in early development.
These results suggest that SRC-1 and KIN-22 play distinct roles
under the control of CSK-1.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Protein tyrosine kinases (PTKs) are present only in meta-
zoans, and many of them, including the Src family kinases
(SFKs), are highly conserved during evolution from sponge
to human [1^4]. The SFKs are non-receptor type PTKs that
are associated with the plasma membrane through their fatty
acylated N-termini, and consist of two peptide-binding mod-
ules, Src homology 2 (SH2) and Src homology 3 (SH3) do-
mains, and a tyrosine kinase domain [5^7]. The SFKs serve as
molecular switches involved in the initiation of a variety of
cellular events in the multicellular animals, including cell
growth and division, cell attachment and movement, di¡er-
entiation, survival, and death [7]. The phosphorylation of
the regulatory tyrosine of SFK is strictly controlled by anoth-
er PTK, the C-terminal Src kinase (Csk) [8,9]. Since Csk is
also evolutionally well conserved, the SFK/Csk circuit is
thought to be essential in controlling the functions of SFKs
in multicellular animals [2,10,11].
Although substantial studies have been accomplished, sig-
naling pathways through SFKs have not been well estab-
lished. Since SFKs are involved in a wide variety of cellular
events, critical points of SFK actions still remain to be de-
¢ned. Furthermore, functional redundancy among nine mem-
bers has hampered the analysis of their individual in vivo
functions [12]. To overcome these di⁄culties, we have decided
to utilize more primitive multicellular animals as an experi-
mental model, and have chosen the soil nematode Caenorhab-
ditis elegans. The genomic information of C. elegans has al-
ready pointed that there are some SFK-related kinases [3].
Recently, it was shown that one of the SFKs, src-1, plays
an essential role in embryonic development and contributes
to spindle orientation and endoderm speci¢cation in early
development [13]. In this report, we have characterized anoth-
er C. elegans SFK gene (kin-22) and a csk gene (csk-1). The
results obtained in this study suggested that SRC-1 and KIN-
22 play distinct roles and are negatively regulated by CSK-1
in C. elegans, and that C. elegans would provide an excellent
model to study the primitive function of SFK members in
vivo.
2. Materials and methods
2.1. Worm cultivation
Wild-type C. elegans Bristol strain (N2) and SU93 (jcIs1) IV were
cultivated at 20‡C on NGM agar plates seeded with the OP-50 strain
of Escherichia coli [14].
2.2. Identi¢cation of csk-1, src-1 and kin-22 genes and plasmid
constructions
The csk-1 (Y48G1C.2), src-1 (Y92H12A.1) and kin-22 (F49B2.5) in
C. elegans were identi¢ed by a simple module architecture research
tool (SMART) search with architecture analysis of Csk and SFKs
consisting of SH3, SH2 and tyrosine kinase domain [15,16]. The
EST clones, yk657d3, yk117f2 and yk256f2 (obtained from Y. Ko-
hara), corresponding to csk-1, src-1 and kin-22, respectively, were
sequenced and subcloned. To assess the gene expression, 5P-promoter
sequences of the genes were introduced into the plasmid pPD95.77
(kindly provided by A. Fire) carrying DsRed2 (Clontech) or green
£uorescent protein (GFP) reporter gene. To obtain csk-1 promo-
ter: :DsRed2 fusion gene, 5P-promoter sequence (5.0 kb) was ampli¢ed
by polymerase chain reaction (PCR) and subcloned into the pPD95.77
vector carrying DsRed2. For src-1 and kin-22 genes, 5P-promoter
sequences (4.9 kb and 2.7 kb, respectively) were ampli¢ed by PCR
and subcloned into the pPD95.77 vector carrying GFP. For expres-
sion of kin-22, kin-22 K268M and kin-22 Y500F, cDNAs were sub-
cloned into the pPD49.26 vector carrying the 5P-regulatory sequence
of kin-22.
2.3. Germline transformation
Germline transformation was carried out as described by Mello et
al. [17]. To express promoter: :reporter fusion gene, 50 ng/Wl of src-1
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promoter: :gfp or kin-22 promoter: :gfp vector was co-injected with 50
ng/Wl csk-1 promoter: :DsRed2 vector into N2 strain. Transgenic ani-
mals were visualized on a Carl Zeiss LSM 510 confocal microscope.
For kin-22 cDNA expression, 50 ng/Wl plasmid was injected into N2
strain together with 50 ng/Wl kin-8 promoter: :gfp as injection marker
[18].
2.4. Yeast growth assay
Saccharomyces cerevisiae YPH499 strain and pESC epitope tagging
vector used in this work were purchased form Stratagene. csk-1 was
subcloned in FLAG-tagged pESC vector and src-1 and kin-22 were
subcloned in myc-tagged pESC vector. Yeast cells were kept in stan-
dard minimal medium lacking the appropriate amino acids for plas-
mid selection [19]. Yeasts were cultured in non-inductive medium
containing dextrose at growth phase and then diluted to 0.01 at
OD600 in medium containing galactose to induce the csk-1 under
the gal-10 promoter or src-1 and kin-22 under the gal-1 promoter.
To assess the yeast growth, OD600 was measured after induction at
indicated time. The protein extracts from yeast cell were obtained by
lysing cell using the bu¡er-glass beads method, as described previously
[20]. The lysis bu¡er contained 50 mM Tris^HCl (pH 8.0), 150 mM
NaCl, 1% NP-40, 0.5% DOC, 1% sodium dodecyl sulfate (SDS), 1 mM
vanadate, 1 mM phenylmethylsulfonyl £uoride (PMSF) and 10 Wg/ml
aprotinin. Proteins were run on SDS gels and immunoblotting.
2.5. Morphological analysis of pharynx
Parental worms of kin-22 transgenic animals were cultured on
NGM plates and laid eggs for 24 h, and then we removed the parental
worms. Laid eggs on NGM plates were cultured at 20‡C for 4 days,
and then the pharynx morphology of adult worms with injection
marker was observed by di¡erential interference contrast (DIC) mi-
croscopy (Olympus BX-60). Two independent lines of each transgenic
worm were assayed.
3. Results and discussion
3.1. Identi¢cation of SRC-1, KIN-22 and CSK-1 as
counterparts of mammalian c-Src, Fyn and Csk
Csk and SFKs share functional domain structures including
SH3, SH2 and tyrosine kinase domain. From SMART search
analysis using the architecture containing SH3, SH2 and ki-
nase domain, some genes were detected in database [15,16].
One of them showed signi¢cant homology to mammalian Csk
and the other two genes showed signi¢cant homology to
mammalian SFKs. The primary structure of Y48G1C.2 that
potentially encompasses the gene for the Csk counterpart
(csk-1) was analyzed by comparison with the sequences of
the EST yk657d3 clone and reverse transcription (RT)-PCR
products. The putative gene product, termed CSK-1, consists
of 539 amino acids and shows 54% identity in the kinase
domain and 47% identity overall with mouse Csk. This
csk-1 gene product was di¡erent from the predicted open
reading frame (ORF) (Y48G1C.2) in database.
Y92H12A.1 and F49B2.5 were previously identi¢ed as src-1
and kin-22 [13,21]. Protein products of these genes have sig-
ni¢cant homology to mammalian SFKs and contain the con-
served autophosphorylation site in the kinase domain and the
negative regulatory tyrosine residue in the carboxyl-terminus,
both of which are hallmarks of the SFKs. SRC-1 and KIN-22
consist of 533 and 507 amino acids, respectively, and have 62
and 61% identity in the kinase domain, and 47 and 50% iden-
tity in overall mouse c-Src and Fyn, respectively (Fig. 1).
There is no signi¢cant homology in the N-terminal unique
domain of SRC-1, KIN-22 and CSK-1, but the amino-termi-
nal fatty acylation signals, another characteristic of SFKs, are
recognized in SRC-1 and KIN-22, but not in CSK-1 (data not
shown).
To con¢rm that CSK-1, SRC-1 and KIN-22 serve as func-
tional homologues of Csk, c-Src and Fyn, respectively, we
characterized these kinases in yeast cells. Expression of
SRC-1 or KIN-22 alone resulted in growth inhibition around
40 h after induction. The extent of growth inhibition is known
to be proportional to the catalytic activity of c-Src [22]. The
expression of CSK-1 alone had no e¡ect on cell growth be-
cause CSK-1 is predicted to be highly speci¢c for the C-ter-
minal tyrosine of SRC-1 and KIN-22. When CSK-1 was co-
expressed with SRC-1 or KIN-22, normal growth was re-
stored. However, co-expression of CSK-1 K300M, a kinase
negative mutant, could not restore normal growth. Further-
more, growth inhibition induced by the expression of SRC-1
Y528F or KIN-22 Y500F, constitutive active mutants having
Phe instead of Tyr at the C-terminal regulatory site, was not
a¡ected by CSK-1 expression (Fig. 2A). These ¢ndings sug-
gest that CSK-1 could target the regulatory tyrosine of SRC-1
and KIN-22 to inhibit their activities. To verify this possibil-
ity, the kinase activities of SRC-1 and KIN-22 in the cells
were measured by immunoblot analysis using anti-phospho-
tyrosine antibody (Fig. 2B). The tyrosine phosphorylation
levels in the cellular proteins re£ect the catalytic activities of
CSK-1, SRC-1 and KIN-22 because tyrosine kinases are ab-
sent from yeast. While the expression of SRC-1 or KIN-22
substantially increased the tyrosine phosphorylation level of
yeast proteins, CSK-1 did not, re£ecting that CSK-1 is highly
speci¢c for SFKs. When CSK-1 was co-expressed with SRC-1
or KIN-22, the tyrosine phosphorylation levels were signi¢-
cantly decreased as compared with the levels induced by
SRC-1 or KIN-22 alone. However, co-expression of kinase-
inactive CSK-1 K300M did not reduce SRC-1- or KIN-22-
induced tyrosine phosphorylation, and the activities of SRC-1
Y528F and KIN-22 Y500F were not inhibited by CSK-1 at
all. These results are consistent with those of growth inhibi-
tion assays, and clearly demonstrate that CSK-1 speci¢cally
Fig. 1. Schematic structure of CSK-1, SRC-1 and KIN-22. The amino acid identity of each domain is calculated between C. elegans and mouse
molecules. The autophosphorylated tyrosines in the kinase domains and the C-terminal regulatory tyrosines are indicated by Y. The cDNA se-
quence data of csk-1 will appear in the DDBJ/EMBL/GenBank databases with the accession number(s) AB096875.
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targets the C-terminal tyrosine of SRC-1 and KIN-22 to neg-
atively regulate their activities. Recently, more primitive or-
thologues of SFKs and Csk have been isolated in Sponge
[2]and Hydra [10]. Taking these lines of information together
with our data, it is likely that SFKs have evolved along with
Csk since the appearance of metazoans, and that the regula-
tion by Csk is indispensable for SFKs to exert their functions.
3.2. Expression patterns of src-1, kin-22 and csk-1
If CSK-1 is a physiological regulator for SRC-1 and KIN-
22, it should be co-expressed with SRC-1 or KIN-22 in the
same cells. To address this, we assessed the tissues in which
the genes were expressed by detecting reporter proteins
(DsRed2 for CSK-1; GFP for SRC-1 or KIN-22) in trans-
genic worms. In Fig. 3A, the expressions of csk-1 and src-1
genes were visualized by the £uorescent images of DsRed2
and GFP, respectively. The expressions of both genes were
widely overlapping, and the co-expression signals were de-
tected in some neurons (ASE, ADF, AVA, AUA, RMDV
and BAG) in the head region, the anchor cell, the vulva, the
cells around the anus, the body wall muscle, pharyngeal
muscles in procorpus and metacorpus and distal tip cells of
gonad. Fig. 3B shows the expression patterns of the reporter
proteins for csk-1 and kin-22 genes. These reporters are
strictly co-expressed in pharyngeal muscles, the vulva and
some cells around anus. These observations indicate that the
expression patterns of src-1 and kin-22 genes are signi¢cantly
di¡erent, and the expression of csk-1 gene overlaps with the
total expression patterns of src-1 and kin-22 genes.
3.3. Functional analysis of SRC-1 and KIN-22
To analyze the functions of SRC-1 and KIN-22 in vivo,
cDNAs encoding these proteins were introduced into the N2
strain under the control of their own promoters. The intro-
Fig. 2. S. cerevisiae based growth assay of the ability of CSK-1 to regulate SRC-1 and KIN-22. A: Growth curves of yeasts expressing indi-
cated gene product; control vector (open squares), CSK-1 (closed squares), SRC-1 or KIN-22 (open circles), SRC-1 and CSK-1 or KIN-22 and
CSK-1 (closed circles), SRC-1 and CSK-1 K300M or KIN-22 and CSK-1 K300M (open triangles), CSK-1 and SRC-1 Y528F or CSK-1 and
KIN-22 Y500F (closed triangles). The time after induction is indicated in hours. B: Immunoblots of lysates prepared from yeasts expressing in-
dicated gene products at 38 h post-induction. Tyrosine phosphorylation of the cellular proteins was detected with anti-phosphotyrosine anti-
body (4G10) (upper panel), SRC-1 or KIN-22 were detected with anti-myc antibody (9E10) (middle panel) and CSK-1 protein was detected
with anti-FLAG antibody (M5) (bottom panel).
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duction of kin-22 cDNA greatly reduced viability in the early
stages of development. By the larval stage, 44.6% (n=121),
30.7% (n=163) and 76.3% (n=139) of worms carrying the
wild-type kin-22 (kin-22), an inactive form of kin-22 (kin-22
K268M) and an active form of kin-22 (kin-22 Y500F), respec-
tively, were dead. Furthermore, substantial numbers of escap-
ers showed an obvious defect in the structure of the pharynx
where the expression of kin-22 was the most prominent (Fig.
4A^D). The expression of kin-22 and kin-22 Y500F caused a
bending of the pharynx structure with higher incidence in the
active form (line 1, 34.5%; line 2, 38.8%) than the wild type
(28.1%, 25.8%). However, kin-22 K268M induced the defect
with much lower incidence (4.33%, 4.93%). These ¢ndings
demonstrate that the pharynx abnormality is dependent on
the kinase activity of KIN-22. The introduction of src-1 also
caused lethality by the stage of larva with the incidences being
44.8% (n=255), 19.6% (n=301) and 44.0% (n=159) for wild-
type src-1, an inactive form and an active form, respectively.
However, there was no apparent abnormality in the escapers
of any type of src-1 transgenic worms (data not shown). These
observations suggest that KIN-22 and SRC-1 play important
roles during the development of C. elegans, and that KIN-22
could involve the morphogenesis or maintenance of the mor-
phology of the pharynx, although its molecular mechanism
remains to be studied.
E¡ects of loss of function of src-1 and kin-22 genes were
examined by RNA interference analysis (RNAi). The RNAi of
src-1 induced a growth arrest of embryo at the stages between
gastrulation and 2-fold stage. This embryonic lethality has
recently been observed in the src-1 deletion mutant [13], sug-
Fig. 3. A: Fluorescent images of the reporter proteins expressed in L3 stage of worms using csk-1 promoter (DsRed2; a, d, g and j) and src-1
promoter (GFP; b, e, h and k). Merged images are shown in c, f, i and l. Whole body images are shown in a^c. Higher magni¢cation images
of pharynx (d^f), vulva (g^i) and tail (j^l). Scale bars are 100 Wm in a and 20 Wm in d, respectively. B: Fluorescent images of the reporter pro-
teins expressed in L3 stage of worms using csk-1 promoter (DsRed2; a, d, g and j) and kin-22 promoter (GFP; b, e, h and k). Merged images
are shown in c, f, i and l. Whole body images are shown in a^c. Higher magni¢cation images of pharynx (d^f), vulva (g^i) and tail (j^l). Scale
bars are 100 Wm in a and 20 Wm in d, respectively.
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gesting that src-1 is an essential gene in embryonic develop-
ment of C. elegans. In contrast, the RNAi analysis for kin-22
gene did not show any overt phenotype (Fig. 5). These results
suggested that SRC-1 and KIN-22 might play distinct func-
tions in C. elegans.
In this study, we have identi¢ed C. elegans orthologues of
mammalian SFKs and Csk. In vitro and in vivo studies using
yeasts and transgenic worms, respectively, suggest that SRC-1
and KIN-22 are regulated by CSK-1 in the same manner as
the mammalian system. Di¡erential expression and functions
of the SFKs in the worms suggest that the SFKs have already
diverged in C. elegans to take their share in responsibility for
important developmental processes. In addition to the abun-
dant genetic information, the small number (only two) of SFK
family members and relatively clear di¡erences in their expres-
sion patterns and functions in C. elegans may be great advan-
tages to de¢ne the primitive functions of SFKs.
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